Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

Background: Sacubitril/Valsartan has been shown to improve mortality and reduce hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The effect of Sacubitril/Valsartan on ejection fraction (EF) and reverse remodeling parameters have not been previously described. M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Cardiovasc Dis
Autori principali: Almufleh, Aws, Marbach, Jeffrey, Chih, Sharon, Stadnick, Ellamae, Davies, Ross, Liu, Peter, Mielniczuk, Lisa
Natura: Artigo
Lingua:Inglês
Pubblicazione: e-Century Publishing Corporation 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768868/
https://ncbi.nlm.nih.gov/pubmed/29348971
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi